Because of naloxone’s ability to reverse opioid overdose and its ease of use, by July 15, 2017, all 50 states and the District of Columbia had passed legislation to improve naloxone access, as one strategy to reduce opioid overdose morbidity and mortality.
This webinar describes systemic barriers faced by patients with HIV and substance use disorders, and discusses steps providers can take to decrease these barriers and support integration of behavioral health and HIV public health interventions.
